TrialThe international journal of neuropsychopharmacology2010

Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial.

Sanjay J Mathew et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.